86
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The clinical impact of paroxysmal arrhythmias on the hospital outcomes of patients admitted with cirrhosis: propensity score matched analysis of 2011–2017 US hospitals

ORCID Icon, , , &
Pages 947-956 | Received 14 Apr 2021, Accepted 07 Sep 2021, Published online: 26 Sep 2021

References

  • Ward CA, Ma Z, Lee SS, et al. Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosis. Am J Physiol. 1997;273(2 Pt 1):G537–G544.
  • Lin R-S, Lee F-Y, Lee S-D, et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophaegeal varices, and hyperdynamic circulation. J Hepatol. 1995;22(2):165–172.
  • Zhong J, Hwang T-C, Richard Adams H, et al. Reduced L-type calcium current in ventricular myocytes from endotoxemic guinea pigs. Am J Physiol Heart Circ Physiol. 1997;273(5):H2312–H2324.
  • Gazawi H, Ljubuncic P, Cogan U, et al. The effects of bile acids on β-adrenoceptors, fluidity, and the extent of lipid peroxidation in rat cardiac membranes. Biochem Pharmacol. 2000;59(12):1623–1628.
  • Mozos I, Costea C, Serban C, et al. Factors associated with a prolonged QT interval in liver cirrhosis patients. J Electrocardiol. 2011;44(2):105–108.
  • Scheiner B, Lindner G, Reiberger T, et al., Acid-base disorders in liver disease. J Hepatol. 2017;67(5):1062–1073.
  • Trevisani F, Merli M, Savelli F, et al. QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. J Hepatol. 2003;38(4):461–467.
  • Trevisani F, Sica G, Mainquà P, et al. Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites. Hepatology. 1999;30(6):1387–1392.
  • Giancane S, Bernardi M, Trevisani F, et al. Autonomic neuropathy in liver cirrhosis: prevalence and association with clinical and laboratory features. Adv Exp Med Biol. 1991;298:295–300.
  • Thuluvath PJ, Triger DR. Autonomic neuropathy and chronic liver disease. Q J Med. 1989;72(268):737–747.
  • MacGilchrist AJ, Reid JL. Impairment of autonomic reflexes in cirrhosis. Am J Gastroenterol. 1990;85(3):288–292.
  • Chaudhry V, Corse AM, O’Brian R, et al. Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study. Hepatology. 1999;29(6):1698–1703.
  • Ramond MJ, Comoy E, Lebrec D. Alterations in isoprenaline sensitivity in patients with cirrhosis: evidence of abnormality of the sympathetic nervous activity. Br J Clin Pharmacol. 1986;21(2):191–196.
  • Bernardi M, Calandra S, Colantoni A, et al. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology. 1998;27(1):28–34.
  • Ma Z, Meddings JB, Lee SS. Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats. Am J Physiol. 1994;267(1 Pt 1):G87–G93.
  • Josefsson A, Fu M, Björnsson E, et al. Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis. BMC Gastroenterol. 2014;14(1):65.
  • Henriksen JH, Gülberg V, Fuglsang S, et al. Q‐T interval (QTC) in patients with cirrhosis: relation to vasoactive peptides and heart rate. Scand J Clin Lab Invest. 2007;67(6):643–653.
  • Lee H, Choi E-K, Rhee T-M, et al. Cirrhosis is a risk factor for atrial fibrillation: a nationwide, population-based study. Liver Int. 2017;37(11):1660–1667.
  • Negru RD, Cojocaru D-C, Felea M, et al. QT interval parameters and ventricular arrhythmic events in liver cirrhosis correlation with severity and etiology. Published online 2017.
  • Gundling F, Schmidtler F, Zelihic E, et al. Frequency of cardiac arrhythmia in patients with liver cirrhoses and evaluation of associated factors. Z Gastroenterol. 2012;50(11):1149–1155.
  • Kerr CR, Humphries KH, Talajic M, et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian registry of atrial fibrillation. Am Heart J. 2005;149(3):489–496.
  • Kato T, Yamashita T, Sagara K, et al. Progressive nature of paroxysmal atrial fibrillation-observations from a 14-year follow-up study-. Circ J. 2004;68(6):568–572.
  • Padfield GJ, Steinberg C, Swampillai J, et al. Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian registry of atrial fibrillation. Heart Rhythm. 2017;14(6):801–807.
  • Veasey RA, Sugihara C, Sandhu K, et al. The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease? J Interv Card Electrophysiol. 2015;44(1):23–30.
  • Page RL, Wilkinson WE, Clair WK, et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 1994;89(1):224–227.
  • Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of atrial fibrillation in elderly subjects (the cardiovascular health study). Am J Cardiol. 1994;74(3):236–241.
  • Lee DU, Fan GH, Ahern RR, et al. The effect of malnutrition on the infectious outcomes of hospitalized patients with cirrhosis: analysis of the 2011-2017 hospital data. Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):269-278.
  • Lee DU, Fan GH, Hastie DJ, et al. The clinical impact of cirrhosis on the hospital outcomes of patients admitted with influenza infection: propensity score matched analysis of 2011-2017 US hospital data. J Clin Exp Hepatol. Published online 2021 February 4;11(5):531–543.
  • Healthcare Cost and Utilization Project (HCUP). 2017 introduction to the HCUP National Inpatient Sample (NIS). U.S. Agency for Healthcare Research and Quality, Rockville, MD; 2019.
  • Houchens R, Ross D, Elixhauser A, et al. Nationwide Inpatient Sample (NIS) redesign final report. U.S. Agency for Healthcare Research and Quality, Rockville MD; 2014.
  • Healthcare Cost and Utilization Project (HCUP). Agency for healthcare research and quality, Rockville. HCUP National Inpatient Sample (NIS) 2012-2017. Published online December 2019.
  • Healthcare Cost and Utilization Project (HCUP). Agency for healthcare research and quality, Rockville. HCUP Nationwide Inpatient Sample (NIS) 2011. Published online June 2013.
  • Elixhauser A, Heslin KC, Owens PL. Healthcare Cost And Utilization Project (HCUP) recommendations for reporting trends using ICD-9-CM and ICD-10-CM/PCS data. U.S. Agency for Healthcare Research and Quality; 2017.
  • Centers for Medicare and Medicaid Services. 2017 ICD-10 PCS code descriptions. Published online August 22, 2016.
  • Centers for Medicare and Medicaid Services (CMS). 2017 ICD-10-CM code descriptions. Published online August 22, 2016.
  • Centers for Medicare and Medicaid Services (CMS). ICD-9-CM and PCS diagnosis and procedure codes descriptions version 32. Published online October 1, 2014.
  • Centers for Medicare and Medicaid Services (CMS). 2017 ICD-10 PCS General Equivalence Mappings (GEMs) – procedure codes. Published online December 1, 2016.
  • Centers for Medicare and Medicaid Services (CMS). 2017 ICD-10-CM General Equivalence Mappings (GEMs) – diagnosis Codes. Published online August 22, 2016.
  • Centers for Medicare and Medicaid Services (CMS). ICD-10 definition of medicare code edits V37.2. Published online August 2020.
  • Centers for Medicare and Medicaid Services (CMS). ICD-10 MS-DRG definitions manual files V37.2. Published online August 2020.
  • Fung KW, Richesson R, Smerek M, et al. Preparing for the ICD-10-CM transition: automated methods for translating ICD codes in clinical phenotype definitions. EGEMS (Wash DC). 2016;4(1):1211.
  • Cherkassky V, Ma Y. Comparison of model selection for regression. Neural Comput. 2003;15(7):1691–1714.
  • Burnham KP, Anderson DR. Multimodel inference: understanding AIC and BIC in model selection. Sociol Methods Res. 2004;33(2):261–304.
  • Chakrabarti A, Ghosh JK. AIC, BIC and recent advances in model selection. In: Bandyopadhyay PS, Forster MR, editors. Philosophy of statistics. North-Holland: 2011:Vol. 7:583–605.
  • Lip GYH, Hee FLLS. Paroxysmal atrial fibrillation. QJM. 2001;94(12):665–678.
  • Brembilla-Perrot B, Marcon O, Blangy H, et al. Prevalence of supraventricular tachycardia and tachyarrhythmias in resuscitated cardiac arrest. Arch Mal Coeur Vaiss. 2006;99(1):33–38.
  • Brembilla-Perrot B, Marçon O, Chometon F, et al., Supraventricular tachyarrhythmia as a cause of sudden cardiac arrest. J Interv Card Electrophysiol. 2006;16(2):97–104.
  • Bänsch D, Böcker D, Brunn J, et al. Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol. 2000;36(2):566–573.
  • Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular Tachycardia: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2016;;133(14):e506-74. .
  • Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. Heart Rhythm. 2018;138(13):e210-e271.
  • Schipperheyn JJ. The pathophysiology of potassium and magnesium disturbances. A cardiac perspective. Drugs. 1984;28(Suppl 1):112–119.
  • Lee SS, Marty J, Mantz J, et al. Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats. Hepatology. 1990;12(3 Pt 1):481–485.
  • Ma Z, Miyamoto A, Lee SS. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology. 1996;110(4):1191–1198.
  • Zavecz JH, Battarbee HD, O’Donnell JM. Cardiac beta-adrenoceptor-effector coupling in portal vein-stenosed rats. Am J Physiol. 1995;268(3 Pt 1):G410–G415.
  • Zavecz JH, Bueno O, Maloney RE, et al. Cardiac excitation-contraction coupling in the portal hypertensive rat. Am J Physiol Gastrointest Liver Physiol. 2000;279(1):G28–G39.
  • Ward CA, Liu H, Lee SS. Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy. Gastroenterology. 2001;121(5):1209–1218.
  • Zambruni A, Trevisani F, Caraceni P, et al. Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol. 2006;44(5):994–1002.
  • Chayanupatkul M, Liangpunsakul S. Cirrhotic cardiomyopathy: review of pathophysiology and treatment. Hepatol Int. 2014;8(3):308–315.
  • Kahan T, Bergfeldt L. Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart. 2005;91(2):250–256.
  • Mozos I. Arrhythmia risk in liver cirrhosis. World J Hepatol. 2015;7(4):662–672.
  • Sandau KE, Funk M, Auerbach A, et al. Update to practice standards for electrocardiographic monitoring in hospital settings: a scientific statement from the American heart association. Circulation. 2017;136(19):e273–e344.
  • Weiss-Guillet E-M, Takala J, Jakob SM. Diagnosis and management of electrolyte emergencies. Best Pract Res Clin Endocrinol Metab. 2003;17(4):623–651.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.